Melanoma, an aggressive form of skin cancer that accounts for 75% of all skin-cancer-related deaths, is often detected later in people with darker skin complexions—and the consequences can be devastating, a Mayo Clinic ...
7 hours ago
0
0
Much of what we know about neurological and psychiatric disorders in humans can be traced back to foundational studies of how animals, such as mice, learn and adapt to various situations. Studying behavioral responses has ...
10 hours ago
0
5
A new research paper was published in Aging, titled, "The association between neighborhood deprivation and DNA methylation in an autopsy cohort."
May 9, 2024
0
0
Discrimination may speed up the biological processes of aging, according to a new study led by researchers at the NYU School of Global Public Health. The research links interpersonal discrimination to changes at the molecular ...
May 9, 2024
0
4
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas, an aggressive type of brain tumor ...
May 9, 2024
0
18
Scientists from Trinity College Dublin have made an important breakthrough that offers promise for developing new immune therapies for cancer. They have discovered that a vaccine adjuvant called C100 promotes potent anti-tumor ...
May 9, 2024
0
19
A new drug could prevent sepsis-related organ failure and death by restoring the health of a patient's blood vessels. Researchers from The University of Queensland and the Queensland Children's Hospital (QCH) have successfully ...
May 9, 2024
0
9
Researchers at MIT, Brigham and Women's Hospital, and Harvard Medical School have developed a potential new treatment for alopecia areata, an autoimmune disorder that causes hair loss and affects people of all ages, including ...
May 9, 2024
0
29
A major clinical trial has found that an additional COVID-19 vaccine dose led to the majority of clinically extremely vulnerable people mounting defensive antibodies against COVID-19.
May 8, 2024
0
86
New research from a multi-disciplinary team at Trinity College Dublin suggests a "tailored vaccine" might hold the key to treating bacteria-driven flares of eczema in children. The work has been published in JCI Insight.
May 8, 2024
0
1
